Oura recently introduced its fourth-generation smart ring, but now it’s focusing on a new partnership with another giant in the health-tech space. Dexcom, known for its glucose sensors and broader health tech, is partnering with Oura to integrate its data into the Oura ecosystem.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a significant impact.

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom. The strategic investment brings Oura’s valuation to more than $5 billion and allows the companies to begin integrating data between Dexcom’s continuous glucose monitoring products and Oura’s smart ring and application.

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.

If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor DexCom and Oura smart rings.

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.